Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EP...(t cash provided by operating activit...),Health

provided by operating activities:

Depreciation and amortization 26,217 25,518

Amortization of premiums on investments, net of

accretion of discounts 5,118 3,379

Stock-based compensation charges 15,012 14,487

Stock-based compensation income tax benefits 3,025 2,031

Excess tax benefit from stock-based compensation (2,510) (13,055)

Gain on sale of stock holdings of Molecular

Profiling Institute, Inc. (1,600) -

Impairment charges 5,086 -

Loss on disposal of property and equipment 38 202

Changes in assets and liabilities:

Accounts receivable 11,403 (15,861)

Inventories (4,270) 2,660

Prepaid expenses 7,060 (6,538)

Other current assets (2,255) (2,756)

Other long term assets (510) (930)

Accounts payable 7,381 1,116

Accrued salaries and employee benefits 4,922 6,328

Other accrued expenses 96 5,343

Income tax payable 2,926 (14,544)

Deferred revenue (3,399) 202

Deferred income tax (961) 794

Deferred rent (10) (88)

Deferred compensation plan liabilities 436 544

Net cash provided by operating activities 159,019 74,560

Investing activities:

Proceeds from sales a
'/>"/>